Clinical trial / 2020
Acute nicotinamide riboside supplementation improved redox markers and specific exercise performance outcomes in older, but not younger, men.
Twelve young and twelve old men received acute nicotinamide riboside (NR) or placebo in a double-blind cross-over study. NR supplementation increased NADH (51% young; 59% old) and NADPH (32% young; 38% old) in both groups, but only in older men did it decrease urine F2-isoprostanes by 18% (P < 0.05) and tend to raise glutathione (P = 0.078). In older individuals, NR improved isometric peak torque by 8% (P = 0.048) and the fatigue index by 15% (P = 0.012), while having no effect on VO2max, concentric peak torque, or physiological performance in young men.
- Study type
- Double-blind cross-over trial
- Who was studied
- 12 young and 12 old men
- What was measured
- Blood/urine redox markers (NAD(P)H, F2-isoprostanes, glutathione) and physical performance (VO2max, muscle strength, fatigue)
THE PAPER
Acute nicotinamide riboside supplementation improves redox homeostasis and exercise performance in old individuals: a double-blind cross-over study.
Dolopikou CF, Kourtzidis IA, Margaritelis NV, Vrabas IS, Koidou I, Kyparos A, Theodorou AA, Paschalis V, Nikolaidis MG. Eur J Nutr, 2020.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.